• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-132 通过多种信号通路为 tau 病提供神经保护。

MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.

机构信息

Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, 60 Fenwood Rd, 9006, Boston, MA, 02115, USA.

Department of Psychiatry, McLean Hospital and Harvard Medical School, Belmont, MA, 02478, USA.

出版信息

Acta Neuropathol. 2018 Oct;136(4):537-555. doi: 10.1007/s00401-018-1880-5. Epub 2018 Jul 7.

DOI:10.1007/s00401-018-1880-5
PMID:29982852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6132948/
Abstract

MicroRNAs (miRNA) regulate fundamental biological processes, including neuronal plasticity, stress response, and survival. Here, we describe a neuroprotective function of miR-132, the miRNA most significantly downregulated in neurons in Alzheimer's disease. We demonstrate that miR-132 protects primary mouse and human wild-type neurons and more vulnerable Tau-mutant neurons against amyloid β-peptide (Aβ) and glutamate excitotoxicity. It lowers the levels of total, phosphorylated, acetylated, and cleaved forms of Tau implicated in tauopathies, promotes neurite elongation and branching, and reduces neuronal death. Similarly, miR-132 attenuates PHF-Tau pathology and neurodegeneration, and enhances long-term potentiation in the P301S Tau transgenic mice. The neuroprotective effects are mediated by direct regulation of the Tau modifiers acetyltransferase EP300, kinase GSK3β, RNA-binding protein Rbfox1, and proteases Calpain 2 and Caspases 3/7. These data suggest miR-132 as a master regulator of neuronal health and indicate that miR-132 supplementation could be of therapeutic benefit for the treatment of Tau-associated neurodegenerative disorders.

摘要

微小 RNA(miRNA)调节基本的生物学过程,包括神经元可塑性、应激反应和存活。在这里,我们描述了 miR-132 的神经保护功能,miR-132 是阿尔茨海默病神经元中下调最显著的 miRNA。我们证明 miR-132 可保护原代小鼠和人类野生型神经元以及更脆弱的 Tau 突变神经元免受淀粉样 β 肽(Aβ)和谷氨酸兴奋性毒性的侵害。它降低了与 tau 病相关的 Tau 的总、磷酸化、乙酰化和切割形式的水平,促进了神经突的伸长和分支,并减少了神经元死亡。同样,miR-132 减轻了 PHF-Tau 病理学和神经退行性变,并增强了 P301S Tau 转基因小鼠的长时程增强作用。神经保护作用是通过直接调节 Tau 修饰物乙酰转移酶 EP300、激酶 GSK3β、RNA 结合蛋白 Rbfox1 以及蛋白酶钙蛋白酶 2 和 Caspases 3/7 来介导的。这些数据表明 miR-132 是神经元健康的主要调节剂,并表明 miR-132 的补充可能对治疗 Tau 相关神经退行性疾病具有治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/13d012f9a8c5/401_2018_1880_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/0be89dc3a7a4/401_2018_1880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/9578d6bf7278/401_2018_1880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/acb0f1ce3f9a/401_2018_1880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/5c88dce8d547/401_2018_1880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/d15222c123ff/401_2018_1880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/dd105ad50f74/401_2018_1880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/206104c77310/401_2018_1880_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/13d012f9a8c5/401_2018_1880_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/0be89dc3a7a4/401_2018_1880_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/9578d6bf7278/401_2018_1880_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/acb0f1ce3f9a/401_2018_1880_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/5c88dce8d547/401_2018_1880_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/d15222c123ff/401_2018_1880_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/dd105ad50f74/401_2018_1880_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/206104c77310/401_2018_1880_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/6132948/13d012f9a8c5/401_2018_1880_Fig8_HTML.jpg

相似文献

1
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.miRNA-132 通过多种信号通路为 tau 病提供神经保护。
Acta Neuropathol. 2018 Oct;136(4):537-555. doi: 10.1007/s00401-018-1880-5. Epub 2018 Jul 7.
2
Astrocytic neuroprotection through induction of cytoprotective molecules; a proteomic analysis of mutant P301S tau-transgenic mouse.星形胶质细胞通过诱导细胞保护分子实现神经保护;突变 P301S tau 转基因小鼠的蛋白质组学分析。
Brain Res. 2011 Sep 2;1410:12-23. doi: 10.1016/j.brainres.2011.06.064. Epub 2011 Jul 7.
3
Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.tau 蛋白与 Harlequin 鼠突变的共同表达导致线粒体功能障碍、tau 蛋白病理和神经退行性变增加。
Neurobiol Aging. 2011 Oct;32(10):1827-38. doi: 10.1016/j.neurobiolaging.2009.10.014. Epub 2009 Nov 25.
4
MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.MicroRNA-223 可保护实验性自身免疫性脑脊髓炎中的神经元免于退化。
Brain. 2019 Oct 1;142(10):2979-2995. doi: 10.1093/brain/awz245.
5
Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.蓝斑核消融加剧 P301S tau 转基因小鼠的认知缺陷、神经病理学和致死性。
J Neurosci. 2018 Jan 3;38(1):74-92. doi: 10.1523/JNEUROSCI.1483-17.2017. Epub 2017 Nov 13.
6
Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.tau蛋白病中的细胞和分子修饰途径:对无脊椎动物模型进行筛选得到的整体情况
J Neurochem. 2016 Apr;137(1):12-25. doi: 10.1111/jnc.13532. Epub 2016 Feb 11.
7
Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.银杏叶提取物 EGb 761 及其特定成分通过自噬溶酶体途径在转 tau 小鼠和培养神经元中诱导保护性蛋白清除。
J Alzheimers Dis. 2018;65(1):243-263. doi: 10.3233/JAD-180426.
8
Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.阿尔茨海默病新型三转基因小鼠模型中tau 蛋白病理加速伴突触和神经元丢失。
Neurobiol Aging. 2013 Nov;34(11):2564-73. doi: 10.1016/j.neurobiolaging.2013.05.003. Epub 2013 Jun 5.
9
Modulation of tau pathology in tau transgenic models.tau 转基因模型中 tau 病理的调制。
Biochem Soc Trans. 2010 Aug;38(4):996-1000. doi: 10.1042/BST0380996.
10
Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer's disease.miR-132/212的下调会损害S-亚硝基化平衡并诱导阿尔茨海默病中的tau蛋白磷酸化。
Neurobiol Aging. 2017 Mar;51:156-166. doi: 10.1016/j.neurobiolaging.2016.12.015. Epub 2016 Dec 27.

引用本文的文献

1
MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammation.微小RNA-132在脂多糖诱导的神经炎症过程中调节大脑中喹啉酸的产生。
Front Immunol. 2025 Aug 26;16:1644783. doi: 10.3389/fimmu.2025.1644783. eCollection 2025.
2
Understanding the Molecular Basis of Miller-Dieker Syndrome.了解米勒-迪克尔综合征的分子基础。
Int J Mol Sci. 2025 Jul 30;26(15):7375. doi: 10.3390/ijms26157375.
3
Protein kinase CK2α' as a dual modulator of neuroimmune signaling and synaptic dysfunction in Tauopathy.蛋白激酶CK2α'作为Tau蛋白病中神经免疫信号和突触功能障碍的双重调节因子。

本文引用的文献

1
Noncoding RNAs in Alzheimer's disease.阿尔茨海默病中的非编码 RNA。
Wiley Interdiscip Rev RNA. 2018 Mar;9(2). doi: 10.1002/wrna.1463. Epub 2018 Jan 12.
2
miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.miRTarBase 更新 2018:一个经过实验验证的 microRNA-靶标相互作用的资源库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302. doi: 10.1093/nar/gkx1067.
3
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells.人类神经胶质瘤干细胞释放的细胞外 RNA 的编码和非编码景观。
Res Sq. 2025 Aug 7:rs.3.rs-7078069. doi: 10.21203/rs.3.rs-7078069/v1.
4
MicroRNAs as biomarkers and molecular mediators of cognitive dysfunction in schizophrenia.微小RNA作为精神分裂症认知功能障碍的生物标志物和分子介质
J Neural Transm (Vienna). 2025 Aug 8. doi: 10.1007/s00702-025-02993-1.
5
The emerging role of miRNAs in biological aging and age-related diseases.微小RNA在生物衰老及与年龄相关疾病中的新作用。
Noncoding RNA Res. 2025 May 5;13:131-152. doi: 10.1016/j.ncrna.2025.05.002. eCollection 2025 Aug.
6
The Role of Tau in Neuronal Function and Neurodegeneration.Tau在神经元功能和神经退行性变中的作用。
Neurol Int. 2025 May 13;17(5):75. doi: 10.3390/neurolint17050075.
7
The Relevance of the Accurate Annotation of Micro and Long Non-Coding RNA Interactions for the Development of Therapies.微小和长链非编码RNA相互作用的准确注释对治疗开发的相关性。
Genes (Basel). 2025 Feb 24;16(3):262. doi: 10.3390/genes16030262.
8
Long non-coding RNAs as key regulators of neurodegenerative protein aggregation.长链非编码RNA作为神经退行性疾病蛋白质聚集的关键调节因子。
Alzheimers Dement. 2025 Feb;21(2):e14498. doi: 10.1002/alz.14498.
9
Exosomes and non-coding RNAs: bridging the gap in Alzheimer's pathogenesis and therapeutics.外泌体与非编码RNA:弥合阿尔茨海默病发病机制与治疗之间的差距
Metab Brain Dis. 2025 Jan 4;40(1):84. doi: 10.1007/s11011-024-01520-7.
10
Exosome-based therapies for inflammatory disorders: a review of recent advances.基于外泌体的炎症性疾病治疗:近期进展综述
Stem Cell Res Ther. 2024 Dec 18;15(1):477. doi: 10.1186/s13287-024-04107-2.
Nat Commun. 2017 Oct 26;8(1):1145. doi: 10.1038/s41467-017-01196-x.
4
Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease.从转录谱推断RNA衰变率突出了阿尔茨海默病的调控程序。
Nat Commun. 2017 Oct 13;8(1):909. doi: 10.1038/s41467-017-00867-z.
5
Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies.细胞外截短的tau蛋白会导致与阿尔茨海默病及其他tau蛋白病相关的早期突触前功能障碍。
Oncotarget. 2017 Apr 22;8(39):64745-64778. doi: 10.18632/oncotarget.17371. eCollection 2017 Sep 12.
6
Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease.剖析非编码RNA在阿尔茨海默病淀粉样蛋白和tau神经病理学积累中的作用。
Mol Neurodegener. 2017 Jul 1;12(1):51. doi: 10.1186/s13024-017-0191-y.
7
ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy.ISS-N1成为首个获美国食品药品监督管理局批准用于治疗脊髓性肌萎缩症的药物。
Transl Neurosci. 2017 Jan 26;8:1-6. doi: 10.1515/tnsci-2017-0001. eCollection 2017 Jan.
8
microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.微小RNA-132:一种在阿尔茨海默病细胞阶段起作用的关键非编码RNA。
FASEB J. 2017 Feb;31(2):424-433. doi: 10.1096/fj.201601308.
9
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.tau 减少可预防神经元丢失,并逆转 tau 病小鼠中的病理性 tau 沉积和播散。
Sci Transl Med. 2017 Jan 25;9(374). doi: 10.1126/scitranslmed.aag0481.
10
Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer's disease.miR-132/212的下调会损害S-亚硝基化平衡并诱导阿尔茨海默病中的tau蛋白磷酸化。
Neurobiol Aging. 2017 Mar;51:156-166. doi: 10.1016/j.neurobiolaging.2016.12.015. Epub 2016 Dec 27.